IPO Announced
Electra Therapeutics IPO
US$350m raised
Lodged Sep 2026 · NASDAQ: ETRA · US$15.00 cash per share
Advisers
Lead managers
- Underwriter
- Legal adviser
- Issuer
- Electra Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Latigo Biotherapeutics IPO Aug 2026 · US$346m · Biotech
- Avere Therapeutics placement Jul 2026 · US$320m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- Braveheart Bio IPO Aug 2026 · US$383m · Biotech
- Korsana Biosciences placement Apr 2026 · US$380m · Biotech
Sources
- Sep 2026 Latham Advises on Electra Therapeutics Upsized Initial Public Offering lw.com
- 17 Sep 2026 Evercore: Active bookrunner on Electra Therapeutics’ initial public offering evercore.com
- 18 Sep 2026 Final IPO prospectus (424B4), Electra Therapeutics, Inc. sec.gov
- 18 Sep 2026 Electra Therapeutics Announces Upsized $350 Million IPO cooley.com



